openPR Logo
Press release

Autoimmune Disease Diagnostics Market Hits US$5.32 Billion in 2023, Anticipated to Surge at 7.17% CAGR from 2024 to 2030 ⅼ Renub Research

02-29-2024 08:35 AM CET | Health & Medicine

Press release from: Renub Research

Autoimmune Disease Diagnostics Market Hits US$5.32 Billion

Global Autoimmune Disease Diagnostics market is projected to be valued at around US$ 8.64 Billion by 2030, as per Renub Research. Autoimmune disease diagnostics normally contain a combination of blood markers, specific signs, and sometimes a tissue biopsy. Autoimmune disorders broaden whilst the immune device attacks its cells due to abnormalities. The failure to detect immune cells, tissues, & organs and produce autoantibodies targeting these cells reasons the immune system to malfunction. Therefore, several tasks are carried out via businesses to create focus approximately autoimmune diseases and their socioeconomic impact, thereby boosting the global usage rates of autoimmune disease diagnostics. Additionally, improved laboratory automation and technological diagnostic improvements drive the expansion of the autoimmune ailment diagnostics market.

Read More:

The global autoimmune disease diagnostics market reached US$5.32 Billion in 2023 and is forecast to grow at a CAGR of 7.17% from 2024 to 2030. The growing burden of autoimmune diseases in different parts of the sector, coupled with growing recognition of health and diseases, creates the need for diagnostics for the early detection of diseases, as a consequence of the marketplace's boom. The introduction of technological developments and growing lab automation rates are estimated to increase the fuel market. Clinicians are adopting advance technology to conduct a multiple test simultaneously, with faster and more specific results. The gradual turnaround time related to conventional disease diagnostic techniques and less standardized assessments for over 80 kinds are some of the shortcomings encouraging laboratories to move towards automation. Moreover, favorable government initiatives are anticipated to reinforce market dynamics positively. Organizations along with the Autoimmunity Centers of Excellence, the Cooperative Study Group for Autoimmune Disease Prevention, and the North American Rheumatoid Arthritis Consortium actively educate sufferers and healthcare experts regarding proper diagnosis and treatment.

Request a free sample copy of the report:

Diagnostics equipment firmly holds the top spot in the global autoimmune disease diagnostics market.

Diagnostics Equipment is the primary leader in the global autoimmune disease diagnostics market, owing to its advanced capabilities and widespread adoption. With its precise and reliable testing methods, diagnostic equipment is crucial in accurately identifying autoimmune conditions, enabling timely intervention and treatment. Its versatility allows for detecting various autoimmune diseases, facilitating comprehensive patient care. As the demand for accurate diagnostic tools continues to rise, diagnostic equipment remains at the forefront, driving advancements in autoimmune disease diagnosis and management. Its pivotal role in healthcare underscores its position as the leading solution in the global autoimmune disease diagnostics market.

Systemic autoimmune diseases claim a notable share of the global autoimmune disease diagnostics market.

Systemic autoimmune diseases (SADs) hold a significant share in the global autoimmune diagnostics market due to their complex nature and varied manifestations. Conditions like rheumatoid arthritis, lupus, and Sjögren's syndrome affect multiple organs, necessitating an accurate diagnosis for effective management. This drives demand for advanced diagnostic tools capable of identifying specific autoimmune markers. Consequently, innovative assays, imaging techniques, and biomarker detection methods tailored to SADs have emerged. With increasing awareness of autoimmune disorders and diagnostic advancements, SADs are expected to maintain and potentially expand their prominence in the autoimmune diagnostics market.

Rheumatic disease diagnostics claim a significant portion of the autoimmune disease diagnostic market.

Rheumatic disease diagnostics, crucial for managing conditions like rheumatoid arthritis and lupus, hold a significant share in autoimmune disease diagnostics. Given their complexity, accurate diagnosis is vital, driving the demand for advanced tools to identify specific biomarkers. Medical imaging, blood tests, and molecular diagnostics are key in this process, enabling early intervention. As awareness grows and diagnostic technology advances, the prominence of rheumatic disease diagnostics in the autoimmune disease market is set to endure and potentially develop further.

Diagnostic centers are anticipated to secure a notable portion of the global autoimmune disease diagnostics market.

Diagnostic centers are poised to capture a substantial share of the global autoimmune disease diagnostics market. These centers are crucial in providing accurate and efficient diagnostic services for autoimmune disorders such as rheumatoid arthritis, lupus, and multiple sclerosis. Equipped with advanced medical technologies and staffed by skilled healthcare professionals, diagnostic centers offer a wide range of tests and procedures to detect autoimmune diseases promptly. Patients rely on these facilities for timely diagnosis, essential for initiating appropriate treatment and disease management strategies. With the increasing prevalence of autoimmune conditions worldwide, the demand for diagnostic services provided by specialized centers is expected to grow, solidifying their position in the diagnostic market for autoimmune diseases.

With more than half of the global population residing in the Asia-Pacific region, it confronts an increasing challenge posed by autoimmune diseases.

The Asia-Pacific region plays a crucial role in the global autoimmune diseases diagnostics market, driven by its significant population and rising disease burden. Factors like changing lifestyles, urbanization, and genetic predispositions contribute to the growing prevalence of autoimmune diseases in the region. This has increased the demand for advanced diagnostic technologies and healthcare services. Moreover, improvements in healthcare infrastructure, higher healthcare expenditure, and government initiatives aimed at enhancing healthcare accessibility are fueling market expansion. Asia-Pacific presents substantial growth potential for stakeholders in the autoimmune diseases diagnostics market as efforts to address early disease detection and prevention continue to gain traction in the region.

Key Player

The global market for autoimmune disease diagnostics includes companies like Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, Bio Merieux SA, Myriad Genetics, Inc., Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc.

Product - Market breakup in 3 viewpoints:
1. Therapeutic & Monitoring Equipment
2. Diagnostics Equipment
3. Drugs

Types - Market breakup in 2 viewpoints:
1. Systemic Autoimmune Disease Diagnostics
2. Localized Autoimmune Disease Diagnostics

Indication - Market breakup in 5 viewpoints:
1. Rheumatic Disease
2. Diabetes
3. Multiple Sclerosis
4. Inflammatory Bowel Disease
5. Others

End-Users - Market breakup in 3 viewpoints:
1. Hospitals
2. Diagnostics Centers
3. Others

Countries - Market Breakup into 25 Countries Autoimmune Diseases Diagnostics Industry
1. North America

1.1 United States
1.2 Canada

2. Europe

2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey

3. Asia Pacific

3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand

4. Latin America

4.1 Brazil
4.2 Mexico
4.3 Argentina

5. Middle East & Africa

5.1 Saudi Arabia
5.2 UAE
5.3 South Africa

All the Key players have been covered from 3 Viewpoints:
• Overview
• Recent Developments
• Revenue Analysis

Company Analysis:
1. Abbott Laboratories
2. Bio-Rad Laboratories
3. Roche Diagnostics
4. Siemens Healthineers
5. Bio Merieux SA
6. Myriad Genetics, Inc.
7. Quest Diagnostics Incorporated
8. Thermo Fisher Scientific Inc.

Browse Related Report:
Liquid Biopsy Market:
Point-of-Care Diagnostics Market:
Next Generation Sequencing Market:

About the Company:

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research
Phone No: +91-120-421-9822 (IND)

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Disease Diagnostics Market Hits US$5.32 Billion in 2023, Anticipated to Surge at 7.17% CAGR from 2024 to 2030 ⅼ Renub Research here

News-ID: 3404957 • Views:

More Releases from Renub Research

Indian spice Market become worth US$7.80 billion in 2023. It is expected to rise at a CAGR of 8.11% from 2024 to 2032 and be worth US$15.74 billion by 2032.
Indian spice Market become worth US$7.80 billion in 2023. It is expected to rise …
Indian spices have been popular worldwide considering that ancient instances because of their authentic taste and texture. They are famous for their aroma and flavor, which complements meals exceptional. Indian spice industry has played a giant position in the last seven decades. Spice growing, processing, production, grading, advertising, and other related industries have long been a key source of profits for people in India. Due to their incomparable aroma, taste,
Global Vacuum Truck Market Size, Share, Growth ⅼ Forecast (2024 - 2032) ⅼ Renub Research
Global Vacuum Truck Market Size, Share, Growth ⅼ Forecast (2024 - 2032) ⅼ Re …
Global Vacuum Truck Market value is anticipated to be about US$ 3.11 billion by 2032. The CAGR for the industry from 2024 to 2032 is 6.53%. Renub Research said that it amounted to US$ 1.76 billion in 2023. Vacuum trucks are innovative machines that split, accumulate, and haul away soil and different particles. Their fundamental layout consists of a truck with an extensive series tank hooked to a vacuum hose. Putting
Lung Cancer Diagnostics Market, Size, Global Forecast, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis
Lung Cancer Diagnostics Market, Size, Global Forecast, Industry Trends, Share, G …
Global lung cancer diagnostics market is projected to attain about US$ 30.84 billion through 2030, as per Renub Research Lung cancers consequences from uncontrolled cell growth, forming loads referred to as tumors. Typically originating from the lining cells of the airlines (bronchi and bronchioles), it is frequently referred to as bronchogenic cancers or carcinoma. Cigarette smoking is the primary cause, contributing to approximately 90% of instances, at the same time
Industrial Enzymes Market Surges Towards US$ 10.10 Billion by 2030, Indicates Market Analysis ⅼ Forecast 2024 - 2030
Industrial Enzymes Market Surges Towards US$ 10.10 Billion by 2030, Indicates Ma …
Global Industrial Enzymes Market size is projected to be priced at around US$ 10.10 billion by 2030, according to Renub Research. Enzymes are proteins that catalyze chemical reactions. As such, enzymes have been widely used to facilitate industrial processes and the production of products, and these enzymes are referred to as industrial enzymes. Although it dates back to ancient times when enzymes were used in baking, brewing, cheese making, etc.,

All 5 Releases

More Releases for Diagnostic

Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Global Tissue Diagnostic Market 2020 Business Strategies – Roche Diagnostic, A …
The Zion Market Research added a new report “Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends
POC Cardiovascular Diagnostic Market Report 2018: Segmentation by Product (Diagn …
Global POC Cardiovascular Diagnostic market research report provides company profile for F. Hoffmann-La Roche, Siemens, Abbott, Biomerieux, Danaher and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Diagnostic Imaging Services Market Trending Technologies and Company Overview 20 …
Diagnostic Imaging Services market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the